clinical trial · NCT07402239
HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management
United Innomed(Shanghai) Limited·N/A·recruiting·n = 330
Heart FailureNOVAtria SystemControl
brief summary
The objective of the HARMONY trial is to evaluate the safety and efficacy of implantable left atrial pressure sensor and interatrial shunt system for the treatment of chronic heart failure with reduced left ventricular ejection fraction (HFrEF, EF ≤ 40%) and New York Heart Association(NYHA) functional Class II or Class III who at baseline are treated with guideline-directed drug and device therapies.
started
Mar 1, 2026
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Feb 11, 2026
official title
The Study of a tHerApeutic and monitoRing Device iMplanted at the Atrial Septum prOvides Heart Failure maNagement in sYmptomatic Patients (HARMONY Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol